Showing results (111-120 of 134) with videos related to
Sort By:
Pageof 14
Journal of Diabetes Investigation|September 29, 2025
Red blood cell distribution width is associated with renal tubular injury in individuals with type 2 diabetesKohsuke Miyataka, Yousuke Kaneko, Taiki Hori, et al.Plos One|December 17, 2016
Plasma Metabolites Predict Severity of Depression and Suicidal Ideation in Psychiatric Patients-A Multicenter Pilot AnalysisDaiki Setoyama, Takahiro A Kato, Ryota Hashimoto, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|May 11, 2025
Utility of Discrepancies Between Friedewald and Martin Equations in Predicting Pathogenic Variants of Familial Hypercholesterolemia in ChildrenRyosuke Tani, Keiji Matsunaga, Tomoko Inoue, et al.Journal of Diabetes Investigation|May 27, 2021
Plasma heparin cofactor II activity is inversely associated with albuminuria and its annual deterioration in patients with diabetesTomoyo Hara, Ryoko Uemoto, Akiko Sekine, et al.Internal Medicine (Tokyo, Japan)|November 5, 2010
Bosentan ameliorated exercise-induced pulmonary arterial hypertension complicated with systemic sclerosisShusuke Yagi, Masashi Akaike, Takashi Iwase, et al.Circulation|June 1, 2013
Androgen receptor promotes sex-independent angiogenesis in response to ischemia and is required for activation of vascular endothelial growth factor receptor signalingSumiko Yoshida, Ken-Ichi Aihara, Yasumasa Ikeda, et al.The Journal of Medical Investigation : JMI|October 16, 2022
An attempt to create a treatment algorithm of central adrenal insufficiency using CRH test, DHEA-S and clinical evaluationYukari Mitsui, Yuto Iizuka, Tomoaki Tanaka, et al.Journal of Atherosclerosis and Thrombosis|October 16, 2022
Plasma Heparin Cofactor II Activity Is Inversely Associated with Hepatic Fibrosis of Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes MellitusTomoyo Hara, Ryoko Uemoto, Akiko Sekine, et al.Blood Advances|January 4, 2018
TAK1 inhibition subverts the osteoclastogenic action of TRAIL while potentiating its antimyeloma effectsHirofumi Tenshin, Jumpei Teramachi, Asuka Oda, et al.Journal of Atherosclerosis and Thrombosis|February 13, 2010
Ezetimibe ameliorates metabolic disorders and microalbuminuria in patients with hypercholesterolemiaShusuke Yagi, Masashi Akaike, Ken-ichi Aihara, et al.Pageof 14